Vero E6 cells were cultured in each well of a 96-well tissue culture plate. The following day, when the cells were approximately 80% confluent, 100 µg/mL of each of the 5 antibodies, as well as 2G4 used as a positive control for neutralization [6], were serially diluted in cDMEM. To this, an equal volume of Ebola virus Makona (GenBank No. KJ660348.2) was added so that each well would receive 100 plaque forming units. The virus-antibody mixture was incubated for 1 hour and then 100 µL of the virus-antibody mixture was added to the 96-well. After incubating the 96-well plate for 1 hour at 37℃, the mixture was removed and 200 µL of 2% FBS DMEM was added to each well. The plate was returned to the 37℃ incubator and plates were read for cytopathic effect 13-day post-infection. This assay was performed in the biosafety level 4 laboratory at the National Microbiology Laboratory, part of the public Health Agency of Canada in Winnipeg, Manitoba, Canada.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.